Zynerba Pharmaceuticals, Inc. Annual Return On Equity in % from 2016 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Zynerba Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2016 to 2022.
  • Zynerba Pharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2023 was -90 %, a 62.2% decline year-over-year.
  • Zynerba Pharmaceuticals, Inc. annual Return On Equity for 2022 was -63.3 %, a 41.3% decline from 2021.
  • Zynerba Pharmaceuticals, Inc. annual Return On Equity for 2021 was -44.8 %, a 41.7% increase from 2020.
  • Zynerba Pharmaceuticals, Inc. annual Return On Equity for 2020 was -76.8 %, a 83.2% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -63.3 -18.5 -41.3% Jan 1, 2022 Dec 31, 2022
2021 -44.8 +32 +41.7% Jan 1, 2021 Dec 31, 2021
2020 -76.8 -34.9 -83.2% Jan 1, 2020 Dec 31, 2020
2019 -41.9 +33.4 +44.4% Jan 1, 2019 Dec 31, 2019
2018 -75.4 -28.7 -61.6% Jan 1, 2018 Dec 31, 2018
2017 -46.6 +26.8 +36.5% Jan 1, 2017 Dec 31, 2017
2016 -73.4 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.